Literature DB >> 26679031

Hyperinflation in COPD exacerbations.

Wouter H van Geffen1, Dirk-Jan Slebos2, Huib A M Kerstjens2.   

Abstract

Mesh:

Year:  2015        PMID: 26679031     DOI: 10.1016/S2213-2600(15)00459-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  7 in total

Review 1.  Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.

Authors:  Jimmy Chong; Bonnie Leung; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2017-09-19

2.  Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.

Authors:  Sadia Janjua; Rebecca Fortescue; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

3.  Functional respiratory imaging: heterogeneity of acute exacerbations of COPD.

Authors:  Wouter H van Geffen; Bita Hajian; Wim Vos; Jan De Backer; Anthony Cahn; Omar S Usmani; Cedric Van Holsbeke; Massimo Pistolesi; Huib Am Kerstjens; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-30

4.  High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.

Authors:  Pieter Veenstra; Nic J G M Veeger; Ralph J H Koppers; Marieke L Duiverman; Wouter H van Geffen
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

5.  Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Wouter H van Geffen; Huib Am Kerstjens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-18

Review 6.  The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update.

Authors:  Nikolaos-Dimitrios Pantzaris; Diamantina-Xanthi Spilioti; Aikaterini Psaromyalou; Ioanna Koniari; Dimitrios Velissaris
Journal:  J Clin Med Res       Date:  2018-06-04

7.  Dynamic hyperinflation induced by the 6-minute pegboard and ring test in hospitalized patients with exacerbated COPD.

Authors:  Cassia Fabiane de Barros; Rosimeire Marcos Felisberto; Kelly Cristina Albanezi Nucci; Andre Luis Pereira de Albuquerque; Elaine Paulin; Christina May Moran de Brito; Wellington Pereira Yamaguti
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.